These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Flaws in analysis lead to misleading conclusions about varenicline's safety in smoking cessation. Singh S; Loke YK BMJ; 2012 Jun; 344():e3873; author reply e4033. PubMed ID: 22693049 [No Abstract] [Full Text] [Related]
3. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. Prochaska JJ; Hilton JF BMJ; 2012 May; 344():e2856. PubMed ID: 22563098 [TBL] [Abstract][Full Text] [Related]
4. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation. Kistler CE; Goldstein AO Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928 [No Abstract] [Full Text] [Related]
5. In brief: Cardiovascular safety of varenicline (Chantix). Med Lett Drugs Ther; 2011 Aug; 53(1371):65. PubMed ID: 21860367 [No Abstract] [Full Text] [Related]
6. Varenicline for smoking cessation: is it a heartbreaker? Hays JT CMAJ; 2011 Sep; 183(12):1346-7. PubMed ID: 21727229 [No Abstract] [Full Text] [Related]
7. More evidence that varenicline harms the heart. Harv Ment Health Lett; 2011 Oct; 28(4):7. PubMed ID: 22125830 [No Abstract] [Full Text] [Related]
14. [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]. Fagerström KO; Gilljam H; Tonstad S Lakartidningen; 2011 Nov 2-8; 108(44):2215-7. PubMed ID: 22165180 [No Abstract] [Full Text] [Related]
15. Varenicline for smoking cessation. Harrison-Woolrych M BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037 [No Abstract] [Full Text] [Related]
16. Varenicline and the evaluation of neuropsychiatric adverse events in smokers. O'Malley SS Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436 [No Abstract] [Full Text] [Related]
17. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Toh S; Baker MA; Brown JS; Kornegay C; Platt R; JAMA Intern Med; 2013 May; 173(9):817-9. PubMed ID: 23529063 [No Abstract] [Full Text] [Related]